SRZ Advises Farallon Capital Management on Successful Proxy Contest to Elect Three New Directors at Exelixis

Schulte Roth & Zabel advised Farallon Capital Management on Farallon’s successful proxy contest at Exelixis, Inc., a company innovating next-generation medicines and regimens for cancer care. All of Farallon’s three nominees were elected to the Board at Exelixis’s 2023 Annual Meeting of Stockholders, which was held on May 31, 2023.

The SRZ team was led by Ele Klein, co-chair of the firm’s Global Shareholder Activism Group, and associate Sean Brownridge. The team also included associates Mario Kranjac, Abraham Schwartz and Erik Son. Partner Adriana Schwartz and associates Danny Goldstein, Vera Lee and Arelys Reyes represented Caligan Partners, which partnered with Farallon in the proxy contest.